The E–R relationship for some safety end points with several therapeutic mAbs seems to have a negative trend, 10 , 11 , 12 , 39 but the mechanism is not well understood or explained.
← all excerpts
Characterizing Exposure-Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects.
1
—
—